Pharmacological bone marrow purging in autologous transplantation: focus on the cyclophosphamide derivatives

This publication has 88 references indexed in Scilit:

• Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclophosphamide, monoclonal antibodies, and magnetic microspheres
  Cancer, 1991
• Development and characterisation of a cyclophosphamide resistant variant of the BNML rat model for acute myelocytic leukaemia
  European Journal of Cancer and Clinical Oncology, 1991
• Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow for acute lymphoblastic leukemia
  Medical and Pediatric Oncology, 1991
• Successful adoptive immunotherapy of minimal residual disease after chemoradiotherapy and transplantation of bone marrow purged of leukaemia with mafosfamide
  Cancer Immunology, Immunotherapy, 1990
• Effects of in vitro treatment with 4-hydroperoxycyclophosphamide and hyperthermia on leukemic progenitor cells.
  The Tohoku Journal of Experimental Medicine, 1989
• Incubation Of Autolocous Bone Marrow Graft with Asta Z 7557: Comparative Studies of Hematological Reconstitution After Purged or Nonpurged Bone Marrow Transplantation
  Pediatric Hematology and Oncology, 1987
• Autologous Bone Marrow Transplantation in Patients with Acute Nonlymphocytic Leukemia, Using ex Vivo Marrow Treatment with 4-Hydroperoxycyclophosphamide
  New England Journal of Medicine, 1986
• Pharmacological purging of bone marrow with reference to autografting
  Clinics in Haematology, 1986
• TRANSPLANTATION OF UNPURGED AUTOLOGOUS BONE-MARROW IN ACUTE MYELOID LEUKAEMIA IN FIRST REMISSION
  The Lancet, 1984
• 4‐Hydroperoxyclophosphamide: a model for eliminating residual human tumour cells and T‐lymphocytes from the bone marrow graft
  British Journal of Haematology, 1982